Morphological evidence that 2-arachidonoylglycerol is a true agonist of human platelets

• References

• 1 Randall MD, Harris D, Kendall DA. et al. Cardiovascular effects of cannabinoids. Pharmacol Ther 2002; 95: 191-202.
• 2 Varga K, Wagner JA, Bridgen DT. et al. Plateletand macrophage-derived endogenous cannabinoids are involved in endotoxininduced hypotension. FASEB J 1998; 12: 1035-44.
• 3 Alberich-Jordà M, Lowenberg B, Delwel R. The peripheral cannabinoid receptor Cb2, a novel oncoprotein, induces a reversible block in neutrophilic differentiation. Blood 2003; 101: 1336-43.
• 4 Maccarrone M, Del Principe D, Finazzi-Agrò A. Endocannabinoids: New physiological (co-)agonists of human platelets. Thromb Haemost 2002; 88: 165-6.
• 5 Maccarrone M, Bari M, Del Principe D. et al. Activation of human platelets by 2-arachidonoylglycerol is enhanced by serotonin. Thromb Haemost 2003; 89: 340-7.
• 6 Kaluzhny Y, Ravid K. Role of apoptotic processes in platelet biogenesis. Acta Haematol 2004; 111: 67-77.
• 7 Wadhawan V, Karim ZA, Mukhopadhyay S. et al. Platelet storage under in vitro condition is associated with calcium-dependent apoptosislike lesions and novel reorganization in platelet cytoskeleton. Arch Biochem Biophys 2004; 422: 183-90.
• 8 Malorni W, Quaranta MG, Straface E. et al. The Rac-activating toxin cytotoxic necrotizing factor 1 oversees NK cell-mediated activity by regulating the actin/microtubule interplay. J Immunol 2003; 171: 4195-202.